Retraction: STK35 gene therapy attenuates endothelial dysfunction and improves cardiac function in diabetes
Frontiers Editorial Office*
A Retraction of the Original Research Article
STK35 gene therapy attenuates endothelial dysfunction and improves cardiac function in diabetes
By Joladarashi D, Zhu Y, Willman M, Nash K, Cimini M, Thandavarayan RA, Youker KA, Song X, Ren D, Li J, Kishore R, Krishnamurthy P and Wang L (2022). Front. Cardiovasc. Med. 8:798091. doi: 10.3389/fcvm.2021.798091
The journal retracts the 13 January 2022 article cited above.
Following publication, concerns were raised regarding the integrity of the images in the published figures. Image duplication concerns were identified in Figures 3D, 4E, 6. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. As a result, the data and conclusions of the article have been deemed unreliable and the article has been retracted.
This retraction was approved by the Chief Editors of Frontiers in Cardiovascular Medicine and the Chief Executive Editor of Frontiers. The authors have not responded to correspondence regarding this retraction.
Citation: Frontiers Editorial Office (2023) Retraction: STK35 gene therapy attenuates endothelial dysfunction and improves cardiac function in diabetes. Front. Cardiovasc. Med. 10:1208579. doi: 10.3389/fcvm.2023.1208579
Received: 19 April 2023; Accepted: 19 April 2023;
Published: 9 May 2023.
Approved by: Ngan F Huang, Stanford University, United States
© 2023 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office research.integrity@frontiersin.org